SEC to review Nasdaq bitcoin options approval after CME challenge

The U.S. Securities and Exchange Commission (SEC) has paused its earlier approval of Nasdaq’s cash-settled bitcoin index options product under the ticker QBTC, pending further review triggered by a legal challenge from CME Group. The SEC initially granted conditional approval for the product in May 2026, anticipating that the Commodity Futures Trading Commission (CFTC) would grant necessary exemptions to allow Nasdaq to offer the options on a securities exchange. However, the product has not launched as these CFTC exemptions have yet to be obtained.

CME Group filed its challenge in June 2026, asserting that since bitcoin is classified as a commodity, any options based directly on bitcoin should fall under the exclusive jurisdiction of the CFTC, not the SEC. CME contends that Nasdaq’s QBTC product competes with CME’s regulated bitcoin futures and options markets without being subject to CFTC regulatory oversight. Additionally, CME warned that allowing Nasdaq’s approval could set a precedent for securities exchanges to list derivatives on commodities broadly, which could blur regulatory lines.

The SEC’s order published on July 31, 2026, maintains the suspension of Nasdaq’s QBTC approval while it reconsiders the situation. Interested parties have been invited to submit comments supporting or opposing the approval by August 24, 2026. The SEC’s prior conditional approval had assumed that CFTC exemptions would make the offering compliant, but CME argues that statutory jurisdiction cannot be circumvented through such exemptions.

This development matters because it highlights the complexity and regulatory tension between the SEC and CFTC over jurisdiction of bitcoin-linked derivatives products. The SEC’s determination on this matter will impact how exchanges can offer bitcoin options and potentially shape regulatory boundaries for other commodity-linked derivatives listed on securities exchanges.